Advanced search
Publication Cover
Clinical and Experimental Hypertension Volume 45, 2023 - Issue 1
Submit an article Journal homepage
2,436
Views
2
CrossRef citations to date
0
Altmetric
Research Article

MicroRNA-98 inhibition accelerates the development of atherosclerosis via regulation of dysfunction of endothelial cell

Huai Yua Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China;b The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, ChinaCorrespondence[email protected]
View further author information
,
Hui Caoa Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China;b The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, ChinaView further author information
&
Hang Yua Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China;b The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, ChinaView further author information
Article: 2206068 | Received 11 Nov 2022, Accepted 18 Apr 2023, Published online: 15 May 2023

References

  • Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–8. doi:10.1038/nature01323.
  • Resnick N, Yahav H, Shay-Salit A, Shushy M, Schubert S, Zilberman LC, Wofovitz E. Fluid shear stress and the vascular endothelium: for better and for worse. Prog Biophys Mol Biol. 2003;81(3):177–99. doi:10.1016/S0079-6107(02)00052-4.
  • Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23_suppl_1):III27–32. doi:10.1161/01.CIR.0000131515.03336.f8.
  • Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341–55. doi:10.1016/j.cell.2011.04.005.
  • DP B. Micrornas: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97. doi:10.1016/S0092-8674(04)00045-5.
  • Quiat D, Olson EN. Micrornas in cardiovascular disease: from pathogenesis to prevention and treatment. J Clin Invest. 2013;123(1):11–18. doi:10.1172/JCI62876.
  • Sheikh SA. Role of plasma soluble lectin like oxidized low-density lipoprotein receptor-1 in severity of cad patients and relationship with microrna-98. Balkan Med J. 2020. doi:10.4274/balkanmedj.galenos.2020.2020.6.243.
  • Hu C, Huang S, Wu F, Ding H. Mir-98 inhibits cell proliferation and induces cell apoptosis by targeting mapk6 in huvecs. Exp Ther Med. 2018;15:2755–60. doi:10.3892/etm.2018.5735.
  • Zheng Z, Zhang G, Liang X, Li T. Lncrna oip5-as1 facilitates ox-ldl-induced endothelial cell injury through the mir-98-5p/hmgb1 axis. Mol Cell Biochem. 2021;476(1):443–55. doi:10.1007/s11010-020-03921-5.
  • Chen Z, Wang M, He Q, Li Z, Zhao Y, Wang W, Ma J, Li Y, Chang G. Microrna-98 rescues proliferation and alleviates ox-ldl-induced apoptosis in huvecs by targeting lox-1. Exp Ther Med. 2017;13(5):1702–10. doi:10.3892/etm.2017.4171.
  • Dai Y, Wu X, Dai D, Li J, Mehta JL. Microrna-98 regulates foam cell formation and lipid accumulation through repression of lox-1. Redox Biol. 2018;16:255–62. doi:10.1016/j.redox.2018.03.003.
  • Fan Z, Yang J, Yang J, Yang C, Guo X. Hmgb1: a promising therapeutic approach for atherosclerosis. Int J Cardiol. 2016;202:507–08. doi:10.1016/j.ijcard.2015.09.101.
  • Rubanyi GM, MA P. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46(3):325–415.
  • Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest. 2005;85(1):9–23. doi:10.1038/labinvest.3700215.
  • Pordzik J, Pisarz K, De Rosa S, Jones AD, Eyileten C, Indolfi C, Malek L, Postula M. The potential role of platelet-related micrornas in the development of cardiovascular events in high-risk populations, including diabetic patients: a review. Front Endocrinol (Lausanne). 2018;9:74. doi:10.3389/fendo.2018.00074.
  • Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678–89. doi:10.1038/nri2156.
  • Langer HF, Chavakis T. Leukocyte-endothelial interactions in inflammation. J Cell Mol Med. 2009;13(7):1211–20. doi:10.1111/j.1582-4934.2009.00811.x.
  • Peng K, Jiang P, Du Y, Zeng D, Zhao J, Li M, Xia C, Xie Z, Wu J. Oxidized low-density lipoprotein accelerates the injury of endothelial cells via circ-usp36/mir-98-5p/vcam1 axis. IUBMB Life. 2021;73(1):177–87. doi:10.1002/iub.2419.
  • Li W, Sama AE, Wang H. Role of hmgb1 in cardiovascular diseases. Curr Opin Pharmacol. 2006;6(2):130–35. doi:10.1016/j.coph.2005.10.010.
  • Vijayakumar EC, Bhatt LK, Prabhavalkar KS. High mobility group box-1 (hmgb1): a potential target in therapeutics. Curr Drug Targets. 2019;20(14):1474–85. doi:10.2174/1389450120666190618125100.
  • Kake S, Kawaguchi H, Nagasato T, Yamada T, Ito T, Maruyama I, Miura N, Tanimoto A. Association between hmgb1 and thrombogenesis in a hyperlipaemia-induced microminipig model of atherosclerosis. In vivo (Brooklyn). 2020;34(4):1871–74. doi:10.21873/invivo.11982.
  • Zhang X, Fernandez-Hernando C. Endothelial hmgb1 (high-mobility group box 1) regulation of ldl (low-density lipoprotein) transcytosis: a novel mechanism of intracellular hmgb1 in atherosclerosis. Arterioscler Thromb Vasc Biol. 2021;41(1):217–19. doi:10.1161/ATVBAHA.120.315517.
  • Andrassy M, Volz HC, Maack B, Schuessler A, Gitsioudis G, Hofmann N, Laohachewin D, Wienbrandt AR, Kaya Z, Bierhaus A, et al. Hmgb1 is associated with atherosclerotic plaque composition and burden in patients with stable coronary artery disease. Plos One. 2012;7(12):e52081. doi:10.1371/journal.pone.0052081.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.